Robyn Jackson, based in Los Angeles, CA, US, is currently a Director of Strategic Accounts Oncology at GSK, bringing experience from previous roles at Novartis, Telix Pharmaceuticals Limited, Medtronic and Mallinckrodt Pharmaceuticals. Robyn Jackson holds a USC Gould School of Law. With a robust skill set that includes Pharmaceutical Industry, Healthcare, Medical Devices, Cardiology, Sales and more, Robyn Jackson contributes valuable insights to the industry.